stars 1 stars 2 stars 3

Advent Life Sciences is a leading trans-Atlantic venture and growth investor focused on building innovative Life Sciences businesses in the UK, Europe and the US. Based in London, we are a highly experienced team with a long-standing track record of entrepreneurial and investment success. Thanks to our technical and scientific expertise, we support companies at every stage of development – from early through to growth-stage – in transforming break-through science into approved medicines and medical products. We invest in a range of sectors within life sciences, with a focus on new drug discovery (small molecules, biologics and new modalities), medtech, enabling technologies and vaccines. As innovative entrepreneurs and pragmatic investors, we bring the cutting-edge approaches and intellectual capital of our experienced team to grow our companies. We work in close alignment with our management teams and partner with them to realise their vision, achieving superior financial returns by delivering new, impactful solutions to patients. Since 2000, the companies in our portfolio have discovered and developed 17 approved medicines and products, to the benefit of patients, physicians, our investors and the life sciences industry.

Website http://www.adventls.com
Revenue $5.1 million
Employees 25 (11 on RocketReach)
Founded 2005
Phone +1 440-207-9322
Technologies
Industry Venture Capital, Venture Capital and Private Equity Principals, Finance, Financial Services, Life Sciences, Lending and Investments
Web Rank 7 Million
Keywords Life Sciences Venture Capital, Biotech Venture Capital, Pharmaceutical Funding, Healthcare Venture Capital, Drug Development Funding, Life Science Startups, Pharmaceutical Startups
Competitors Baird Capital, Canaan, OrbiMed, Life Sciences Partners (LSP), Sofinnova Investments, Domain Associates, New Enterprise Associates (NEA), MPM BioImpact, ARCH Venture Partners, Abingworth +48 more (view full list)

Advent Life Sciences Questions

The Advent Life Sciences annual revenue was $5.1 million in 2026.

Shahzad Malik is the General Partner of Advent Life Sciences.

11 people are employed at Advent Life Sciences.

Top Advent Life Sciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users